PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Sees Significant Growth in Short Interest

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 51,769 shares, an increase of 1,271.7% from the April 30th total of 3,774 shares. Based on an average trading volume of 347,170 shares, the days-to-cover ratio is presently 0.1 days.

PharmaTher Stock Down 6.6%

Shares of PHRRF stock opened at $0.05 on Thursday. PharmaTher has a one year low of $0.04 and a one year high of $0.55. The company has a 50 day moving average price of $0.05 and a 200 day moving average price of $0.07.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.